OPEN END TURBO BULL OPTIONSSCHEIN - ROCHE GS Share Price

Certificat

DE000HC5DQ16

Market Closed - BOERSE MUENCHEN 01:16:30 26/06/2024 am IST
5.57 EUR -1.76% Intraday chart for OPEN END TURBO BULL OPTIONSSCHEIN - ROCHE GS
Current month+67.27%
1 month+77.96%
Date Price Change
25/24/25 5.57 -1.76%
24/24/24 5.67 +3.66%
21/24/21 5.47 +5.80%
20/24/20 5.17 -0.19%
19/24/19 5.18 +3.39%

Real-time BOERSE MUENCHEN

Last update June 26, 2024 at 01:16 am IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC5DQ1
ISINDE000HC5DQ16
Date issued 24/03/2023
Strike 200.9 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 6.44
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 9.92
Lowest since issue 1.54

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
253.4 CHF
Average target price
278.1 CHF
Spread / Average Target
+9.73%
Consensus